APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artificial Intelligence in Medical Software

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Artificial Intelligence in Medical Software Market Analysis and Forecast 2026-2032

4 January 2026196 pages

Choose your research edition.

Industry ResearchArtificial Intelligence in Medical Software Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Intelligence in Medical Software Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Artificial Intelligence in Medical Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Intelligence in Medical Software Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Artificial Intelligence in Medical Software Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Artificial Intelligence in Medical Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Artificial Intelligence in Medical Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Artificial Intelligence in Medical Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Artificial Intelligence in Medical Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Artificial Intelligence in Medical Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Artificial Intelligence in Medical Software include 2bPrecise, CliniSys, Fabric Genomics, Flatiron Health, Foundation Medicine, Gene42, Human Longevity, IBM and Koninklijke Philips, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Artificial Intelligence in Medical Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Artificial Intelligence in Medical Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Artificial Intelligence in Medical Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Artificial Intelligence in Medical Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Artificial Intelligence in Medical Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Artificial Intelligence in Medical Software revenue, projected growth trends, production technology, application and end-user industry.

Artificial Intelligence in Medical Software Segment by Company

2bPrecise

CliniSys

Fabric Genomics

Flatiron Health

Foundation Medicine

Gene42

Human Longevity

IBM

Koninklijke Philips

LifeOmic Health

Pierian

SOPHiA GENETICS

Syapse

Tempus

Translational Software

Artificial Intelligence in Medical Software Segment by Type

Image Recognition

Natural Language Processing

Others

Artificial Intelligence in Medical Software Segment by Application

Drug Discovery

Precision Medicine

Others

Artificial Intelligence in Medical Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Intelligence in Medical Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Intelligence in Medical Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Intelligence in Medical Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Artificial Intelligence in Medical Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Artificial Intelligence in Medical Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Intelligence in Medical Software revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Artificial Intelligence in Medical Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Image Recognition Major Player Table 3. Natural Language Processing Major Player Table 4. Others Major Player Table 5. Global Artificial Intelligence in Medical Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Drug Discovery Major Player Table 7. Precision Medicine Major Player Table 8. Others Major Player Table 9. Artificial Intelligence in Medical Software Industry Trends Table 10. Artificial Intelligence in Medical Software Industry Drivers Table 11. Artificial Intelligence in Medical Software Industry Opportunities and Challenges Table 12. Artificial Intelligence in Medical Software Industry Restraints Table 13. Global Artificial Intelligence in Medical Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Artificial Intelligence in Medical Software Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Artificial Intelligence in Medical Software Market Share by Region (2021-2026) Table 16. Global Artificial Intelligence in Medical Software Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Artificial Intelligence in Medical Software Market Share by Region (2027-2032) Table 18. Global Artificial Intelligence in Medical Software Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Artificial Intelligence in Medical Software Revenue Market Share by Players (2021-2026) Table 20. Global Artificial Intelligence in Medical Software Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Artificial Intelligence in Medical Software Key Players Headquarters & Area Served Table 22. Global Artificial Intelligence in Medical Software Players, Product Type & Application Table 23. Global Artificial Intelligence in Medical Software Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Artificial Intelligence in Medical Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Artificial Intelligence in Medical Software Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Artificial Intelligence in Medical Software Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Artificial Intelligence in Medical Software Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Artificial Intelligence in Medical Software Revenue Market Share by Type (2021-2026) Table 30. Global Artificial Intelligence in Medical Software Revenue Market Share by Type (2027-2032) Table 31. Global Artificial Intelligence in Medical Software Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Artificial Intelligence in Medical Software Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Artificial Intelligence in Medical Software Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Artificial Intelligence in Medical Software Revenue Market Share by Application (2021-2026) Table 35. Global Artificial Intelligence in Medical Software Revenue Market Share by Application (2027-2032) Table 36. 2bPrecise Company Information Table 37. 2bPrecise Business Overview Table 38. 2bPrecise Artificial Intelligence in Medical Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. 2bPrecise Artificial Intelligence in Medical Software Product Portfolio Table 40. 2bPrecise Recent Development Table 41. CliniSys Company Information Table 42. CliniSys Business Overview Table 43. CliniSys Artificial Intelligence in Medical Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. CliniSys Artificial Intelligence in Medical Software Product Portfolio Table 45. CliniSys Recent Development Table 46. Fabric Genomics Company Information Table 47. Fabric Genomics Business Overview Table 48. Fabric Genomics Artificial Intelligence in Medical Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Fabric Genomics Artificial Intelligence in Medical Software Product Portfolio Table 50. Fabric Genomics Recent Development Table 51. Flatiron Health Company Information Table 52. Flatiron Health Business Overview Table 53. Flatiron Health Artificial Intelligence in Medical Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Flatiron Health Artificial Intelligence in Medical Software Product Portfolio Table 55. Flatiron Health Recent Development Table 56. Foundation Medicine Company Information Table 57. Foundation Medicine Business Overview Table 58. Foundation Medicine Artificial Intelligence in Medical Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Foundation Medicine Artificial Intelligence in Medical Software Product Portfolio Table 60. Foundation Medicine Recent Development Table 61. Gene42 Company Information Table 62. Gene42 Business Overview Table 63. Gene42 Artificial Intelligence in Medical Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Gene42 Artificial Intelligence in Medical Software Product Portfolio Table 65. Gene42 Recent Development Table 66. Human Longevity Company Information Table 67. Human Longevity Business Overview Table 68. Human Longevity Artificial Intelligence in Medical Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Human Longevity Artificial Intelligence in Medical Software Product Portfolio Table 70. Human Longevity Recent Development Table 71. IBM Company Information Table 72. IBM Business Overview Table 73. IBM Artificial Intelligence in Medical Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. IBM Artificial Intelligence in Medical Software Product Portfolio Table 75. IBM Recent Development Table 76. Koninklijke Philips Company Information Table 77. Koninklijke Philips Business Overview Table 78. Koninklijke Philips Artificial Intelligence in Medical Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Koninklijke Philips Artificial Intelligence in Medical Software Product Portfolio Table 80. Koninklijke Philips Recent Development Table 81. LifeOmic Health Company Information Table 82. LifeOmic Health Business Overview Table 83. LifeOmic Health Artificial Intelligence in Medical Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. LifeOmic Health Artificial Intelligence in Medical Software Product Portfolio Table 85. LifeOmic Health Recent Development Table 86. Pierian Company Information Table 87. Pierian Business Overview Table 88. Pierian Artificial Intelligence in Medical Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Pierian Artificial Intelligence in Medical Software Product Portfolio Table 90. Pierian Recent Development Table 91. SOPHiA GENETICS Company Information Table 92. SOPHiA GENETICS Business Overview Table 93. SOPHiA GENETICS Artificial Intelligence in Medical Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. SOPHiA GENETICS Artificial Intelligence in Medical Software Product Portfolio Table 95. SOPHiA GENETICS Recent Development Table 96. Syapse Company Information Table 97. Syapse Business Overview Table 98. Syapse Artificial Intelligence in Medical Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Syapse Artificial Intelligence in Medical Software Product Portfolio Table 100. Syapse Recent Development Table 101. Tempus Company Information Table 102. Tempus Business Overview Table 103. Tempus Artificial Intelligence in Medical Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Tempus Artificial Intelligence in Medical Software Product Portfolio Table 105. Tempus Recent Development Table 106. Translational Software Company Information Table 107. Translational Software Business Overview Table 108. Translational Software Artificial Intelligence in Medical Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Translational Software Artificial Intelligence in Medical Software Product Portfolio Table 110. Translational Software Recent Development Table 111. North America Artificial Intelligence in Medical Software Revenue by Type (2021-2026) & (US$ Million) Table 112. North America Artificial Intelligence in Medical Software Revenue by Type (2027-2032) & (US$ Million) Table 113. North America Artificial Intelligence in Medical Software Revenue by Application (2021-2026) & (US$ Million) Table 114. North America Artificial Intelligence in Medical Software Revenue by Application (2027-2032) & (US$ Million) Table 115. North America Artificial Intelligence in Medical Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Artificial Intelligence in Medical Software Revenue by Country (2021-2026) & (US$ Million) Table 117. North America Artificial Intelligence in Medical Software Revenue by Country (US$ Million) & (2027-2032) Table 118. Europe Artificial Intelligence in Medical Software Revenue by Type (2021-2026) & (US$ Million) Table 119. Europe Artificial Intelligence in Medical Software Revenue by Type (2027-2032) & (US$ Million) Table 120. Europe Artificial Intelligence in Medical Software Revenue by Application (2021-2026) & (US$ Million) Table 121. Europe Artificial Intelligence in Medical Software Revenue by Application (2027-2032) & (US$ Million) Table 122. Europe Artificial Intelligence in Medical Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Artificial Intelligence in Medical Software Revenue by Country (2021-2026) & (US$ Million) Table 124. Europe Artificial Intelligence in Medical Software Revenue by Country (US$ Million) & (2027-2032) Table 125. China Artificial Intelligence in Medical Software Revenue by Type (2021-2026) & (US$ Million) Table 126. China Artificial Intelligence in Medical Software Revenue by Type (2027-2032) & (US$ Million) Table 127. China Artificial Intelligence in Medical Software Revenue by Application (2021-2026) & (US$ Million) Table 128. China Artificial Intelligence in Medical Software Revenue by Application (2027-2032) & (US$ Million) Table 129. Asia Artificial Intelligence in Medical Software Revenue by Type (2021-2026) & (US$ Million) Table 130. Asia Artificial Intelligence in Medical Software Revenue by Type (2027-2032) & (US$ Million) Table 131. Asia Artificial Intelligence in Medical Software Revenue by Application (2021-2026) & (US$ Million) Table 132. Asia Artificial Intelligence in Medical Software Revenue by Application (2027-2032) & (US$ Million) Table 133. Asia Artificial Intelligence in Medical Software Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Asia Artificial Intelligence in Medical Software Revenue by Region (US$ Million) & (2021-2026) Table 135. Asia Artificial Intelligence in Medical Software Revenue by Region (US$ Million) & (2027-2032) Table 136. SAMEA Artificial Intelligence in Medical Software Revenue by Type (2021-2026) & (US$ Million) Table 137. SAMEA Artificial Intelligence in Medical Software Revenue by Type (2027-2032) & (US$ Million) Table 138. SAMEA Artificial Intelligence in Medical Software Revenue by Application (2021-2026) & (US$ Million) Table 139. SAMEA Artificial Intelligence in Medical Software Revenue by Application (2027-2032) & (US$ Million) Table 140. SAMEA Artificial Intelligence in Medical Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. SAMEA Artificial Intelligence in Medical Software Revenue by Country (2021-2026) & (US$ Million) Table 142. SAMEA Artificial Intelligence in Medical Software Revenue by Country (US$ Million) & (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Artificial Intelligence in Medical Software Image Figure 2. Global Artificial Intelligence in Medical Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artificial Intelligence in Medical Software Market Size Share 2021 VS 2025 VS 2032 Figure 4. Image Recognition Image Figure 5. Natural Language Processing Image Figure 6. Others Image Figure 7. Global Artificial Intelligence in Medical Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Artificial Intelligence in Medical Software Market Size Share 2021 VS 2025 VS 2032 Figure 9. Drug Discovery Image Figure 10. Precision Medicine Image Figure 11. Others Image Figure 12. Global Artificial Intelligence in Medical Software Market Size (US$ Million) & (2021-2032) Figure 13. Global Artificial Intelligence in Medical Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Artificial Intelligence in Medical Software Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Artificial Intelligence in Medical Software Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Artificial Intelligence in Medical Software Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Artificial Intelligence in Medical Software Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Artificial Intelligence in Medical Software Revenue Market Share by Type (2021-2032) Figure 20. Global Artificial Intelligence in Medical Software Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Artificial Intelligence in Medical Software Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Artificial Intelligence in Medical Software Revenue Market Share by Application (2021-2032) Figure 23. North America Artificial Intelligence in Medical Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Artificial Intelligence in Medical Software Revenue Share by Type (2021-2032) Figure 25. North America Artificial Intelligence in Medical Software Revenue Share by Application (2021-2032) Figure 26. North America Artificial Intelligence in Medical Software Revenue Share by Country (2021-2032) Figure 27. United States Artificial Intelligence in Medical Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Artificial Intelligence in Medical Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Artificial Intelligence in Medical Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Artificial Intelligence in Medical Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Artificial Intelligence in Medical Software Revenue Share by Type (2021-2032) Figure 32. Europe Artificial Intelligence in Medical Software Revenue Share by Application (2021-2032) Figure 33. Europe Artificial Intelligence in Medical Software Revenue Share by Country (2021-2032) Figure 34. Germany Artificial Intelligence in Medical Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Artificial Intelligence in Medical Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Artificial Intelligence in Medical Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Artificial Intelligence in Medical Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Artificial Intelligence in Medical Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Artificial Intelligence in Medical Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Artificial Intelligence in Medical Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Artificial Intelligence in Medical Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Artificial Intelligence in Medical Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Artificial Intelligence in Medical Software Revenue Share by Type (2021-2032) Figure 44. China Artificial Intelligence in Medical Software Revenue Share by Application (2021-2032) Figure 45. Asia Artificial Intelligence in Medical Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Artificial Intelligence in Medical Software Revenue Share by Type (2021-2032) Figure 47. Asia Artificial Intelligence in Medical Software Revenue Share by Application (2021-2032) Figure 48. Asia Artificial Intelligence in Medical Software Revenue Share by Region (2021-2032) Figure 49. Japan Artificial Intelligence in Medical Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Artificial Intelligence in Medical Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Artificial Intelligence in Medical Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Artificial Intelligence in Medical Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Artificial Intelligence in Medical Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Artificial Intelligence in Medical Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Artificial Intelligence in Medical Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Artificial Intelligence in Medical Software Revenue Share by Type (2021-2032) Figure 57. SAMEA Artificial Intelligence in Medical Software Revenue Share by Application (2021-2032) Figure 58. SAMEA Artificial Intelligence in Medical Software Revenue Share by Country (2021-2032) Figure 59. Brazil Artificial Intelligence in Medical Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Artificial Intelligence in Medical Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Artificial Intelligence in Medical Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Artificial Intelligence in Medical Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Artificial Intelligence in Medical Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Artificial Intelligence in Medical Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Artificial Intelligence in Medical Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Artificial Intelligence in Medical Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Artificial Intelligence in Medical Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Artificial Intelligence in Medical Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Artificial Intelligence in Medical Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Image Recognition
  • Natural Language Processing
  • Others
Applications
  • Drug Discovery
  • Precision Medicine
  • Others
Companies covered
  • 2bPrecise
  • CliniSys
  • Fabric Genomics
  • Flatiron Health
  • Foundation Medicine
  • Gene42
  • Human Longevity
  • IBM
  • Koninklijke Philips
  • LifeOmic Health
  • Pierian
  • SOPHiA GENETICS
  • Syapse
  • Tempus
  • Translational Software

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Artificial Intelligence in Medical Software Market by Type
  3. 1.2.1 Global Artificial Intelligence in Medical Software Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Image Recognition
  5. 1.2.3 Natural Language Processing
  6. 1.2.4 Others
  7. 1.3 Artificial Intelligence in Medical Software Market by Application
  8. 1.3.1 Global Artificial Intelligence in Medical Software Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Drug Discovery
  10. 1.3.3 Precision Medicine
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Artificial Intelligence in Medical Software Market Dynamics
  1. 2.1 Artificial Intelligence in Medical Software Industry Trends
  2. 2.2 Artificial Intelligence in Medical Software Industry Drivers
  3. 2.3 Artificial Intelligence in Medical Software Industry Opportunities and Challenges
  4. 2.4 Artificial Intelligence in Medical Software Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Artificial Intelligence in Medical Software Market Perspective (2021-2032)
  2. 3.2 Global Artificial Intelligence in Medical Software Growth Trends by Region
  3. 3.2.1 Global Artificial Intelligence in Medical Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Artificial Intelligence in Medical Software Market Size by Region (2021-2026)
  5. 3.2.3 Global Artificial Intelligence in Medical Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Artificial Intelligence in Medical Software Revenue by Players
  2. 4.1.1 Global Artificial Intelligence in Medical Software Revenue by Players (2021-2026)
  3. 4.1.2 Global Artificial Intelligence in Medical Software Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Artificial Intelligence in Medical Software Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Artificial Intelligence in Medical Software Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Artificial Intelligence in Medical Software Key Players Headquarters & Area Served
  7. 4.4 Global Artificial Intelligence in Medical Software Players, Product Type & Application
  8. 4.5 Global Artificial Intelligence in Medical Software Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Artificial Intelligence in Medical Software Market CR5 and HHI
  11. 4.6.3 2025 Artificial Intelligence in Medical Software Tier 1, Tier 2, and Tier 3
5 Artificial Intelligence in Medical Software Market Size by Type
  1. 5.1 Global Artificial Intelligence in Medical Software Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Artificial Intelligence in Medical Software Revenue by Type (2021-2032)
  3. 5.3 Global Artificial Intelligence in Medical Software Revenue Market Share by Type (2021-2032)
6 Artificial Intelligence in Medical Software Market Size by Application
  1. 6.1 Global Artificial Intelligence in Medical Software Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Artificial Intelligence in Medical Software Revenue by Application (2021-2032)
  3. 6.3 Global Artificial Intelligence in Medical Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 2bPrecise
  2. 7.1.1 2bPrecise Company Information
  3. 7.1.2 2bPrecise Business Overview
  4. 7.1.3 2bPrecise Artificial Intelligence in Medical Software Revenue and Gross Margin (2021-2026)
  5. 7.1.4 2bPrecise Artificial Intelligence in Medical Software Product Portfolio
  6. 7.1.5 2bPrecise Recent Developments
  7. 7.2 CliniSys
  8. 7.2.1 CliniSys Company Information
  9. 7.2.2 CliniSys Business Overview
  10. 7.2.3 CliniSys Artificial Intelligence in Medical Software Revenue and Gross Margin (2021-2026)
  11. 7.2.4 CliniSys Artificial Intelligence in Medical Software Product Portfolio
  12. 7.2.5 CliniSys Recent Developments
  13. 7.3 Fabric Genomics
  14. 7.3.1 Fabric Genomics Company Information
  15. 7.3.2 Fabric Genomics Business Overview
  16. 7.3.3 Fabric Genomics Artificial Intelligence in Medical Software Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Fabric Genomics Artificial Intelligence in Medical Software Product Portfolio
  18. 7.3.5 Fabric Genomics Recent Developments
  19. 7.4 Flatiron Health
  20. 7.4.1 Flatiron Health Company Information
  21. 7.4.2 Flatiron Health Business Overview
  22. 7.4.3 Flatiron Health Artificial Intelligence in Medical Software Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Flatiron Health Artificial Intelligence in Medical Software Product Portfolio
  24. 7.4.5 Flatiron Health Recent Developments
  25. 7.5 Foundation Medicine
  26. 7.5.1 Foundation Medicine Company Information
  27. 7.5.2 Foundation Medicine Business Overview
  28. 7.5.3 Foundation Medicine Artificial Intelligence in Medical Software Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Foundation Medicine Artificial Intelligence in Medical Software Product Portfolio
  30. 7.5.5 Foundation Medicine Recent Developments
  31. 7.6 Gene42
  32. 7.6.1 Gene42 Company Information
  33. 7.6.2 Gene42 Business Overview
  34. 7.6.3 Gene42 Artificial Intelligence in Medical Software Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Gene42 Artificial Intelligence in Medical Software Product Portfolio
  36. 7.6.5 Gene42 Recent Developments
  37. 7.7 Human Longevity
  38. 7.7.1 Human Longevity Company Information
  39. 7.7.2 Human Longevity Business Overview
  40. 7.7.3 Human Longevity Artificial Intelligence in Medical Software Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Human Longevity Artificial Intelligence in Medical Software Product Portfolio
  42. 7.7.5 Human Longevity Recent Developments
  43. 7.8 IBM
  44. 7.8.1 IBM Company Information
  45. 7.8.2 IBM Business Overview
  46. 7.8.3 IBM Artificial Intelligence in Medical Software Revenue and Gross Margin (2021-2026)
  47. 7.8.4 IBM Artificial Intelligence in Medical Software Product Portfolio
  48. 7.8.5 IBM Recent Developments
  49. 7.9 Koninklijke Philips
  50. 7.9.1 Koninklijke Philips Company Information
  51. 7.9.2 Koninklijke Philips Business Overview
  52. 7.9.3 Koninklijke Philips Artificial Intelligence in Medical Software Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Koninklijke Philips Artificial Intelligence in Medical Software Product Portfolio
  54. 7.9.5 Koninklijke Philips Recent Developments
  55. 7.10 LifeOmic Health
  56. 7.10.1 LifeOmic Health Company Information
  57. 7.10.2 LifeOmic Health Business Overview
  58. 7.10.3 LifeOmic Health Artificial Intelligence in Medical Software Revenue and Gross Margin (2021-2026)
  59. 7.10.4 LifeOmic Health Artificial Intelligence in Medical Software Product Portfolio
  60. 7.10.5 LifeOmic Health Recent Developments
  61. 7.11 Pierian
  62. 7.11.1 Pierian Company Information
  63. 7.11.2 Pierian Business Overview
  64. 7.11.3 Pierian Artificial Intelligence in Medical Software Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Pierian Artificial Intelligence in Medical Software Product Portfolio
  66. 7.11.5 Pierian Recent Developments
  67. 7.12 SOPHiA GENETICS
  68. 7.12.1 SOPHiA GENETICS Company Information
  69. 7.12.2 SOPHiA GENETICS Business Overview
  70. 7.12.3 SOPHiA GENETICS Artificial Intelligence in Medical Software Revenue and Gross Margin (2021-2026)
  71. 7.12.4 SOPHiA GENETICS Artificial Intelligence in Medical Software Product Portfolio
  72. 7.12.5 SOPHiA GENETICS Recent Developments
  73. 7.13 Syapse
  74. 7.13.1 Syapse Company Information
  75. 7.13.2 Syapse Business Overview
  76. 7.13.3 Syapse Artificial Intelligence in Medical Software Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Syapse Artificial Intelligence in Medical Software Product Portfolio
  78. 7.13.5 Syapse Recent Developments
  79. 7.14 Tempus
  80. 7.14.1 Tempus Company Information
  81. 7.14.2 Tempus Business Overview
  82. 7.14.3 Tempus Artificial Intelligence in Medical Software Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Tempus Artificial Intelligence in Medical Software Product Portfolio
  84. 7.14.5 Tempus Recent Developments
  85. 7.15 Translational Software
  86. 7.15.1 Translational Software Company Information
  87. 7.15.2 Translational Software Business Overview
  88. 7.15.3 Translational Software Artificial Intelligence in Medical Software Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Translational Software Artificial Intelligence in Medical Software Product Portfolio
  90. 7.15.5 Translational Software Recent Developments
8 North America
  1. 8.1 North America Artificial Intelligence in Medical Software Revenue (2021-2032)
  2. 8.2 North America Artificial Intelligence in Medical Software Revenue by Type (2021-2032)
  3. 8.2.1 North America Artificial Intelligence in Medical Software Revenue by Type (2021-2026)
  4. 8.2.2 North America Artificial Intelligence in Medical Software Revenue by Type (2027-2032)
  5. 8.3 North America Artificial Intelligence in Medical Software Revenue Share by Type (2021-2032)
  6. 8.4 North America Artificial Intelligence in Medical Software Revenue by Application (2021-2032)
  7. 8.4.1 North America Artificial Intelligence in Medical Software Revenue by Application (2021-2026)
  8. 8.4.2 North America Artificial Intelligence in Medical Software Revenue by Application (2027-2032)
  9. 8.5 North America Artificial Intelligence in Medical Software Revenue Share by Application (2021-2032)
  10. 8.6 North America Artificial Intelligence in Medical Software Revenue by Country
  11. 8.6.1 North America Artificial Intelligence in Medical Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Artificial Intelligence in Medical Software Revenue by Country (2021-2026)
  13. 8.6.3 North America Artificial Intelligence in Medical Software Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Artificial Intelligence in Medical Software Revenue (2021-2032)
  2. 9.2 Europe Artificial Intelligence in Medical Software Revenue by Type (2021-2032)
  3. 9.2.1 Europe Artificial Intelligence in Medical Software Revenue by Type (2021-2026)
  4. 9.2.2 Europe Artificial Intelligence in Medical Software Revenue by Type (2027-2032)
  5. 9.3 Europe Artificial Intelligence in Medical Software Revenue Share by Type (2021-2032)
  6. 9.4 Europe Artificial Intelligence in Medical Software Revenue by Application (2021-2032)
  7. 9.4.1 Europe Artificial Intelligence in Medical Software Revenue by Application (2021-2026)
  8. 9.4.2 Europe Artificial Intelligence in Medical Software Revenue by Application (2027-2032)
  9. 9.5 Europe Artificial Intelligence in Medical Software Revenue Share by Application (2021-2032)
  10. 9.6 Europe Artificial Intelligence in Medical Software Revenue by Country
  11. 9.6.1 Europe Artificial Intelligence in Medical Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Artificial Intelligence in Medical Software Revenue by Country (2021-2026)
  13. 9.6.3 Europe Artificial Intelligence in Medical Software Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Artificial Intelligence in Medical Software Revenue (2021-2032)
  2. 10.2 China Artificial Intelligence in Medical Software Revenue by Type (2021-2032)
  3. 10.2.1 China Artificial Intelligence in Medical Software Revenue by Type (2021-2026)
  4. 10.2.2 China Artificial Intelligence in Medical Software Revenue by Type (2027-2032)
  5. 10.3 China Artificial Intelligence in Medical Software Revenue Share by Type (2021-2032)
  6. 10.4 China Artificial Intelligence in Medical Software Revenue by Application (2021-2032)
  7. 10.4.1 China Artificial Intelligence in Medical Software Revenue by Application (2021-2026)
  8. 10.4.2 China Artificial Intelligence in Medical Software Revenue by Application (2027-2032)
  9. 10.5 China Artificial Intelligence in Medical Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Artificial Intelligence in Medical Software Revenue (2021-2032)
  2. 11.2 Asia Artificial Intelligence in Medical Software Revenue by Type (2021-2032)
  3. 11.2.1 Asia Artificial Intelligence in Medical Software Revenue by Type (2021-2026)
  4. 11.2.2 Asia Artificial Intelligence in Medical Software Revenue by Type (2027-2032)
  5. 11.3 Asia Artificial Intelligence in Medical Software Revenue Share by Type (2021-2032)
  6. 11.4 Asia Artificial Intelligence in Medical Software Revenue by Application (2021-2032)
  7. 11.4.1 Asia Artificial Intelligence in Medical Software Revenue by Application (2021-2026)
  8. 11.4.2 Asia Artificial Intelligence in Medical Software Revenue by Application (2027-2032)
  9. 11.5 Asia Artificial Intelligence in Medical Software Revenue Share by Application (2021-2032)
  10. 11.6 Asia Artificial Intelligence in Medical Software Revenue by Country
  11. 11.6.1 Asia Artificial Intelligence in Medical Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Artificial Intelligence in Medical Software Revenue by Country (2021-2026)
  13. 11.6.3 Asia Artificial Intelligence in Medical Software Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Artificial Intelligence in Medical Software Revenue (2021-2032)
  2. 12.2 SAMEA Artificial Intelligence in Medical Software Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Artificial Intelligence in Medical Software Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Artificial Intelligence in Medical Software Revenue by Type (2027-2032)
  5. 12.3 SAMEA Artificial Intelligence in Medical Software Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Artificial Intelligence in Medical Software Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Artificial Intelligence in Medical Software Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Artificial Intelligence in Medical Software Revenue by Application (2027-2032)
  9. 12.5 SAMEA Artificial Intelligence in Medical Software Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Artificial Intelligence in Medical Software Revenue by Country
  11. 12.6.1 SAMEA Artificial Intelligence in Medical Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Artificial Intelligence in Medical Software Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Artificial Intelligence in Medical Software Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst